SARM1 allosteric inhibitor (Tenvie Therapeutics)

N/A

Report date: 2025/03/03 16:41:22
NME

Base Information

Drug NameSARM1 allosteric inhibitor (Tenvie Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD(+) hydrolase SARM1 allosteric Inhibitor
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsEye DiseasesPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTenvie Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTenvie Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEye DiseasesPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A